We are live on
!
Find out more
Nicholas Hoffman & Company Portfolio holdings
AUM
$4.74B
Turnover
9.12%
1-Year Est. Return
18.12%
This Fund
S&P 500
This Quarter
Est. Return
+6.31%
1 Year Est. Return
+18.12%
3 Year Est. Return
+65.12%
5 Year Est. Return
+53.27%
10 Year Est. Return
+210.2%
AUM
$255M
AUM Growth
+$17.4M
(+7.3%)
Cap. Flow
+$3.23M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
40.98%
Holding
173
New
9
Increased
70
Reduced
65
Closed
7
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.37M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$874K |
| 3 |
SLB Ltd
SLB
|
+$547K |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$522K |
| 5 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$518K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$639K |
| 2 |
Chevron
CVX
|
+$538K |
| 3 |
GSK
GSK
|
+$425K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$359K |
| 5 |
TSMC
TSM
|
+$339K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.6% |
| 2 | Consumer Staples | 12.2% |
| 3 | Technology | 10.83% |
| 4 | Financials | 9.85% |
| 5 | Healthcare | 7.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
iShares Russell 2000 ETF
IWM
$77.5B
| $2.04M | 0.8% |
13,345
-359
| -3% | -$53.9K |
2016 Q2
6 quarters
|
|
27
PepsiCo
PEP
$175B
| $2.03M | 0.8% |
16,900
+76
| +0.5% | +$8.68K |
2016 Q2
6 quarters
|
|
28
Accenture
ACN
$138B
| $1.94M | 0.76% |
12,672
-118
| -0.9% | -$17.1K |
2016 Q2
6 quarters
|
|
29
Vanguard Morningstar Total Stock Market ETF
VTI
$697B
| $1.89M | 0.74% |
13,780
+172
| +1% | +$23K |
2017 Q3
1 quarter
|
|
30
MiMedx Group
MDXG
$683M
| $1.88M | 0.74% |
149,385
-20,000
| -12% | -$244K |
2016 Q2
6 quarters
|
|
31
PPG Industries
PPG
$24B
| $1.86M | 0.73% |
15,927
-25
| -0.2% | -$2.88K |
2016 Q2
6 quarters
|
|
|
32
Chevron
CVX
$430B
| $1.78M | 0.7% |
14,189
-4,535
| -24% | -$538K |
2016 Q2
6 quarters
|
|
33
Kimberly-Clark
KMB
$34.6B
| $1.76M | 0.69% |
14,588
+135
| +0.9% | +$15.7K |
2016 Q2
6 quarters
|
|
34
Vanguard Total International Stock ETF
VXUS
$161B
| $1.75M | 0.69% |
30,836
+2
| +0% | +$112 |
2016 Q2
6 quarters
|
|
35
DuPont de Nemours
DD
$17.8B
| $1.72M | 0.67% |
9,521
-678
| -7% | -$122K |
2017 Q3
1 quarter
|
|
36
Duke Energy
DUK
$92.7B
| $1.65M | 0.65% |
19,637
+83
| +0.4% | +$7.25K |
2016 Q2
6 quarters
|
|
37
Verizon
VZ
$184B
| $1.64M | 0.64% |
30,994
+576
| +2% | +$28.3K |
2016 Q2
6 quarters
|
|
38
Colgate-Palmolive
CL
$73.9B
| $1.63M | 0.64% |
21,653
-73
| -0.3% | -$5.33K |
2016 Q2
6 quarters
|
|
39
Cisco
CSCO
$433B
| $1.53M | 0.6% |
39,970
-514
| -1% | -$18.4K |
2016 Q2
6 quarters
|
|
40
Caterpillar
CAT
$338B
| $1.52M | 0.6% |
9,672
-983
| -9% | -$136K |
2016 Q2
6 quarters
|
|
41
iShares MSCI EAFE Growth ETF
EFG
$15B
| $1.5M | 0.59% |
18,606
| – | – |
2016 Q4
4 quarters
|
|
|
42
Walmart Inc
WMT
$935B
| $1.49M | 0.59% |
45,321
-20,892
| -32% | -$639K |
2016 Q2
6 quarters
|
|
43
Southern Company
SO
$103B
| $1.48M | 0.58% |
30,772
+587
| +2% | +$29.9K |
2016 Q2
6 quarters
|
|
44
Automatic Data Processing
ADP
$113B
| $1.48M | 0.58% |
12,622
-21
| -0.2% | -$2.4K |
2016 Q2
6 quarters
|
|
45
IBM
IBM
$221B
| $1.47M | 0.58% |
10,047
-81
| -0.8% | -$11.8K |
2016 Q2
6 quarters
|
|
46
American Express
AXP
$212B
| $1.42M | 0.56% |
14,341
-534
| -4% | -$50.9K |
2016 Q2
6 quarters
|
|
47
United Parcel Service
UPS
$83.2B
| $1.4M | 0.55% |
11,719
-1,484
| -11% | -$174K |
2016 Q2
6 quarters
|
|
48
Exelon
EXC
$43.8B
| $1.39M | 0.54% |
49,269
-1,506
| -3% | -$43.3K |
2016 Q2
6 quarters
|
|
49
eBay
EBAY
$54.7B
| $1.37M | 0.54% |
36,382
-223
| -0.6% | -$8.28K |
2016 Q2
6 quarters
|
|
50
Target
TGT
$71.2B
| $1.33M | 0.52% |
20,402
+2,316
| +13% | +$140K |
2016 Q2
6 quarters
|
|
Similar funds
PTC
Nicholas Hoffman & Company's Q4 2017 Portfolio in Review
As of Q4 2017, Nicholas Hoffman & Company held 173 positions worth $255M, up 7.3% from $237M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Nicholas Hoffman & Company's Q4 2017 filing shows 9 new, 70 increased, 65 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K. The largest sale was Walmart Inc, an estimated $639K.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 38% a quarter earlier, followed by Consumer Staples and Technology.
- Nicholas Hoffman & Company's largest Q4 2017 buy was State Street SPDR S&P Pharmaceuticals ETF: 10,289 shares worth $448K.
- Nicholas Hoffman & Company added most to Vanguard S&P 500 ETF in Q4 2017, an estimated $2.37M increase.
- Nicholas Hoffman & Company's biggest Q4 2017 reduction was Walmart Inc, cutting an estimated $639K.
- Nicholas Hoffman & Company fully exited Celgene Corp in Q4 2017, selling an estimated $260K.
- Nicholas Hoffman & Company's ten largest holdings make up 41% of its $255M portfolio in Q4 2017.
- Nicholas Hoffman & Company opened 9 new positions and closed 7 in Q4 2017.
- Nicholas Hoffman & Company's portfolio value rose 7.3% quarter-over-quarter to $255M.
Based on Nicholas Hoffman & Company's 13F filing for Q4 2017, filed 9 Feb 2018.